Alnylam Pharmaceuticals Discontinues Revusiran Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. NUAI
6. MSFT
7. ACN
8. AMZN
9. FFAI
10. PAA

Go back to Alnylam Pharmaceuticals Discontinues Revusiran Development
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 244.64 +5.08 (2.12%)
Previous Close $239.56    52 Week High $109.10 
Open $240.37    52 Week Low $31.38 
Day High $245.61    P/E N/A 
Day Low $237.97    EPS $-1.45 
Volume 210,407